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EGF-induced adipose tissuemesothelial cells undergo
functional vascular smooth muscle differentiation
CC Lachaud1, J Lo´pez-Beas1, B Soria*,1,2,3 and A Hmadcha*,1,2,3
Recent studies suggested that the post-natal mesothelium retain differentiative potential of the embryonic mesothelium, which
generates fibroblasts and vascular smooth muscle cells (VSMCs), in developing coelomic organs via epithelial-to-mesenchymal
transition (EMT). Whether adult mesothelial cells (MCs) are able to give rise to functional VSMCs in vitro and which are the factors
and mechanisms directing this process remain largely unknown. Here, we isolated adipose tissue MCs (ATMCs) from adult mice,
and demonstrated that ATMCs cultured in a serum-containing media supplemented with epidermal growth factor (EGF)
efficiently increased both their proliferation and EMT above levels found in only serum-containing media cultures. EGF-induced
ATMCs gained phosphorylation of the EGF receptor and activated simultaneously ILK/Erk1/2, PI3K/Akt and Smad2/3-dependent
pathways. Sequential subculture onto collagen-I surface efficiently improved their vasculogenic EMT towards cells featuring
VSMCs (a-SMA, calponin, caldesmon, SM22a, desmin, SM-MHC, smoothelin-B and PDGFR-b) that could actively contract in
response to receptor and non-receptor-mediated vasoactive agonists. Overall, our results indentify EGF signalling as a robust
vasculogenic inductive pathway for ATMCs, leading to their transdifferentiation into functional VSMC-like cells.
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Stem cell-based pro-angiogenic therapies hold great promise
to revascularize ischemic tissues in patients with acute
myocardial infarction or chronic limb ischemia.1–4 The plasticity
of pluripotent embryonic stem cells (ESCs) and induced
pluripotent stem (iPS) cells allows their easy derivation towards
Isl-1þ multipotent cardiovascular progenitors that clonally give
rise to cardiomyocytes, vascular smooth muscle cells (VSMCs)
and endothelial cells,5,6 the major cell types of cardiovascular
tissues. Safety concerns, differentiation efficiency, overcoming
immune rejection and the inherent tumourigenicity of pluripo-
tent stem cells, however, remains a major issue hindering their
clinical application7,8 and will require the validation of efficient
gating strategies allowing the purification of ESC- and iPS-
derived multipotent cardiovascular progenitors for future use in
cardiovascular regenerative medicine.
Adult tissues retain a small subset of resident undiffer-
entiated stem cells that can self-renew asymmetrically to
generate committed progenitors for the replenishment of the
different cellular phenotypes that are lost during normal tissue
turnover. Although adult stem cells display restricted lineage
differentiation potential and limited proliferative capacities,
their lack of tumourigenicity has attracted great attention for
establishing safe cell-based regenerative therapies.9–11 Stro-
mal mesenchymal stem cells (MSCs) are multipotent stem
cells residing around the vasculature of virtually all organs and
vascularized tissues.12,13 It is now widely accepted that
MSCs display significant immunosuppressive activity14 and
angiogenic potential and improve long-term neovasculariza-
tion outcomes of ischemic tissues4 mainly through their
paracrine secretion of pro-angiogenic factors such as bFGF,
EGF, PDGF-BB, VEGF and TGFb1, rather by a direct
incorporation into the neovasculature as it was initially
thought.15 Despite the extensive focus on the pro-angiogenic
potential of MSCs, the identification of new sources of adult
stem cells with neovascularization potential remains a goal
that is under research.
The adult mesothelium is a squamous epithelial layer of
mesoderm origin lining coelomic cavities and the visceral
organs housed within. Cumulating evidence indicates that the
adult mesothelium is a rich reservoir of mesothelial cells
(MCs) with pro-vasculogenic potential.16–19 The adult
mesothelium was thought to be a ‘quiescent tissue’ solely
endowed with physiological functions such as to maintain
serosal integrity and inflammation and to secrete large
amounts of ‘lubricants’ to favour the correct sliding of opposite
serosal layers (i.e., for the beating heart). A recent report,
however, set a breakthrough in this concept showing that the
post-natal mesothelium remains a source of progenitor cells
giving rise to fibroblasts and VSMCs in visceral organs of
healthy mice.19 Furthermore, it was also shown that MCs give
rise to hepatic stellate cells and myofibroblasts in injured
liver.20 Another striking example recently demonstrates that
the mesothelium is a source for adipocytes that often
physically attach to the visceral organs.21
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The findings that adult MCs of human and rodent origin can
recapitulate in vitro an epithelial-to-mesenchymal transition
(EMT) and acquire SMCs markers in response to provasculo-
genic and morphogenic growth factors (i.e, TGF-b1, PDGF-
BB, bFGF and EGF)10,16,17,22–24 led to the hypothesis that
adult MCs may retain the differentiative potential of embryonic
MCs, which were shown to generate fibroblasts and VSMCs in
the developing heart, lung, gut and liver.25–30 We recently
pushed onward this concept by demonstrating that adult
mouse uterine MCs (UtMCs) subjected to provasculogenic
culture undergo EMT towards progenitors that can subse-
quently acquire properties of differentiated VSMCs upon
sequential subculture.18 Despite these exiting findings unco-
vering an unexpected mesodermal plasticity and vasculogenic
potential for adult MCs, the factors and mechanisms inducing
and directing their vasculogenic differentiation towards a
functional VSMCs phenotype remain largely unknown.
The visceral adipose tissue (AT) is composed of several
adipose depots, including mesenteric, epididymal white AT
and perirenal depots. In humans, the major visceral AT depot
corresponds to the greater omentum, a large fold of the
peritoneum.31 In mice, the major visceral AT depots are
attached to the uterus and ovaries in females and the
epididyme and testes in males. Its tremendous remodelling
capacity allows its rapid adaptation to an excess food intake
through adipocyte hyperplasia, a process that is closely
coupled with neovascularization.32,33
The expansion and neovascularization potential of the
visceral AT is likely to indicate that its surrounding mesothe-
lium retain strong vasculogenic potential, a particularity that
should make this tissue a valuable source of cells for
cardiovascular regenerative therapy.
Herein, we show that a gentle trypsinization of the adult
mouse uterine AT can efficiently and reliably detach a highly
enriched population of AT mesothelial cells (ATMCs) from its
covering mesothelium. ATMCs cultured in a high glucose-
based media (BMe) with serum and 50 ng/ml of epidermal
growth factor (EGF; termed BMeþ 50EGF) could actively
proliferate and acquire EMT, progenitor and cardiovascular
developmental markers. Upon repeated subculture onto
collagen type I-coated surface, ATMCs drastically reduced
their proliferation rate while improving in turn their transdiffer-
entiation towards fibroblastic cells displaying molecular and
functional characteristics of differentiated VSMCs.
Results
Immunophenotype characterization of trypsin isolated
ATMCs. A gentle trypsinization of the adult mouse uterine
AT could efficiently disrupt and detach its outermost
mesothelium layer typically in the form of small sheets of
flattened MCs that rapidly adopted ‘grap-like’ morphologies
once resuspended in serum-containing media (Figure 1a).
Flow cytometry and immunofluorescence analysis of trypsin
isolated cells could confirm their wide immunoexpression of
the epithelial tight junction proteins ZO-1, E-cadherin and
b-catenin and cell adhesion molecules CD29 and CD54
(Figures 1b and c). Whole-mount immunofluorescence
analysis of the uterine AT could confirm the constitutive
expression of these markers in its outermost mesothelium
layer (Supplementary Figure 1). Freshly trypsin isolated
cells, however, contained a significant subset of cells
expressing the pan-haematopoietic marker CD45
(23.86±7.96%) and in much less extent of cells expressing
the monocyte and macrophage marker CD11b
(5.16±5.33%), suggesting phenotypic heterogeneity within
the CD45þ subset. Whole-mount immunofluorescence
analysis of the uterine AT mesothelium further indicated that
it contains a significant population of CD45þ cells, and
hence explain why CD45þ cells were detached during
trypsinization together with ATMCs (Supplementary
Figure 1). Trypsin isolated cells heterogeneously expressed
Sca1 (50.9±17.9%) and CD90.2 (37.4±28.3%), two mar-
kers that were accordingly found to be expressed hetero-
geneously in the AT mesothelium (Supplementary Figure 1).
The lack of expression of endothelial markers expression
(CD31 and CD106) among trypsin isolated cells strongly
suggests that our trypsinization procedure was not disrupting
and detaching the submesothelial microvasculature to any
significant extent. Consistent with their mesothelial nature,
trypsin isolated cells cultured for 5 days in BMe (media
lacking EGF) could establish a cobblestone monolayer of
cells that widely immunoexpressed the mesothelial markers
WT1, CD54, ZO-1 and b-catenin (Figure 1d).
Early EGF-induced ATMCs undergo EMT and acquire
vascular smooth muscle (SM) markers expression. During
the 15 days of our differentiation protocol (Figure 2a),
ATMCs that were cultured in BMeþ 50EGF rapidly initiated
proliferation and also morphological changes consistent with
EMT. The subset of the early EGF-induced ATMCs, which was
actively proliferating mainly, corresponded to small polygonal to
rounded refringent cells (Figure 2b), a subset of ATMCs that
was found to strongly express the nuclear Ki-67 proliferation
antigen (Supplementary Figure 2).
Other subset of the early EGF-induced ATMCs rather
displayed transitional epitheloid–fibroblastoid morphologies,
which are consistent with EMT. Their ongoing EMT was also
confirmed by immunofluorescence analysis on the basis of
their gain of expression of a-SMA and Smtn-B after only 3
days in culture (Figure 2b and Table 1). Immunofluorescence
analysis of the early EGF-induced ATMCs revealed their
increased expression of Gata-4, gain of expression of the
progenitor cells marker nestin and also in distinct degrees of
a-SMA, SM22a, calponin, caldesmon, desmin, SMM,
SM-MHC, Smtn-B and PDGFR-b markers, indicating hence
that they had already initiated a vasculogenic EMT
(Supplementary Figure 3 and Table 1).
We used quantitative real-time PCR (qPCR) analysis to
quantify the change in expression of EMT, SM and cardiac
genes suffered by the EGF-induced ATMCs through their
culture period. Consistent with their initiation of EMT, the early
EGF-induced ATMCs displayed a strong up-expression of
snail, a master gene upregulated during EMT (Figure 3a). In
less extent, they also displayed a significant increase in their
expression of other EMT genes such as twist and slug
(Figure 3a). Accordingly, the epithelial genes, E-cadherin and
CK18, were in turn strongly downregulated. In less extent,
WT1 expression was also slightly decreased through their
time culture period.
Vasculogenic potential of adult mesothelial cells
CC Lachaud et al
2
Cell Death and Disease
In further confirmation of their initiation of a vasculogenic
EMT, qPCR analysis also demonstrated that the EGF-
induced ATMCs displayed in distinct degrees a clear up-
expression of the SM genes calponin, a-SMA, SM22a,
desmin, SM-MHC and h-caldesmon through time culture
(Figure 3a).
Early EGF-induced ATMCs acquire expression of a
subset of cardiac muscle markers. Interestingly, the
EGF-induced ATMCs also displayed significant up-expression
of the cardiac genes cTnT, SERCA2 and MLC2a (Figure 3d).
Other genes expressed during cardiomyogenesis (BPM2,
Flk1, c-Kit, Isl1, Hrt1, Tbx5 and Nkx2.5) and in mature
cardiomyocytes (cTnI, MHC-b and ANF) were by contrast
strongly downregulated in the early EGF-induced ATMCs,
suggesting hence that they were not undergoing an accurate
cardiomyogenic differentiation program (Figure 3e). Support-
ing these findings are also western blot analysis experiments
of the EGF-induced ATMCs, which clearly evidenced their
strong up-expression of PDGFR-b, a-SMA and Smtn-B
through time culture, finding that is consistent with the
emergence of a VSMCs phenotype (Figure 4b). Although
Figure 1 Efficient recovery of ATMCs by gentle trypsinization of the uterine AT. (a) Aspect of uterine AT depots before (left) and after (middle) quirurgical separation from
uterine cords. Right photograph shows representative aspect of cells isolated through gentle trypsinization of AT. Trypsin typically detached small sheets (spot) of flattened
epitheloid cells that adopted ‘grape-like’ structure after full retraction. (b) Trypsin isolated cells widely immunoexpressed epithelial (b-catenin, E-cadherin and ZO-1) and CD54.
They also immunoexpressed more heterogeneously Sca1 and lacked expression of the VSMCs marker smoothelin-B (Smtn-B). (c) Flow cytometry analysis expression results
of several surface markers in trypsin isolated cells (n¼ 5). (d) Trypsin isolated cells cultured for 5 days in BMe exhibited cobblestone morphologies (phase contrast) and
immunoexpressed WT1, CD54, ZO-1, E-cadherin and b-catenin. (b and d) Nuclei are counterstained in blue with Hoechst 33342
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the expression of cardiac transcription factor Gata-4 was
progressively upregulated through time culture, the EGF-
induced ATMCs, however, only minimally acquired expression
of the cardiac markers sACTN and cTnT (Figure 4c).
Interestingly, double immunofluorescence labellings could
corroborate the dual VSMCs and cardiomyocytic traits
acquired by the early EGF-induced ATMCs, as many of them
were found to co-immunoexpress the VSMCs marker Smtn-B
together with a low expression of the cardiac contractile
proteins sACTN and cTnT (Supplementary Figure 4).
EGF-induced ATMCs display activation of the Erk1/2,
PI3/Akt and Smad-dependent (Smad2/3) pathways. We
next used western blot analysis to determine the signalling
pathways that were activated in the EGF-induced ATMCs.
As expected, we found that the EGF-induced ATMCs
displayed an active phosphorylation of the EGF receptor
(Tyr1068) and of its downstream signalling pathways
molecules AKT and ERK1/2 (Figure 4d). Noticeably, the
EGF-induced ATMCs also displayed a robust phosphoryla-
tion of Smad-2, which is a downstream mediator of TGFb1
Figure 2 Efficient transdifferentiation of ATMCs towards VSM-like cells through subsequent subculture into BMeþ 50EGF. (a) Schematic representation of the stepwise
protocol used to direct ATMCs towards VSM-like cells. (b) Immunofluorescence characterization of ATMCs transdifferentiation towards VSM-like cells. Left images show
representative phase contrast pictures of ATMCs cultured for 1, 3, 5, 10 and 15 days in BMeþ 50EGF. Left to right, shows corresponding immunofluorescence expression
patterns against epithelial (b-catenin and CK19), mesothelial (WT1) and VSMCs (a-SMA and Smtn-B) markers
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signalling,24,34 suggesting thus that the EGF-induced ATMCs
may secrete TGFb1 in a paracrine manner.
EGF-induced ATMCs acquire characteristics of differ-
entiated VSMCs through sequential subculture. Sequen-
tial subculture of the EGF-induced ATMCs at decreasing
seeding density onto a collagen I-coated surface resulted in a
drastic loss of their proliferation (Supplementary Figure 2)
favouring in turn their maturation towards VSM-like cells as
evidenced by their robust increase in expression of the SM
genes calponin, a-SMA, SM22a, desmin, SM-MHC and
h-caldesmon evidenced by qPCR analysis (Figure 3c).
A strong up-expression of these SM markers through
subculture steps 1 and 2 could also be confirmed at the
protein level by immunofluorescence (Figure 2b and
Supplementary Figure 3) and flow cytometry (Figure 5a
and Supplementary Figure 5a) approaches. Western blot
analysis also indicated a strong up-expression of a-SMA,
PDGFR-b and Smtn-B during subculture steps 1 and 2,
markers that are consistent with the establishment in
subculture of a mature VSMC-like phenotype (Figure 4b).
In addition, the EGF-induced ATMCs also increased
moderately their expression of the cardiac genes cTnT and
MLC2a during subculture (Figure 3c). By contrast, other
genes expressed during early cardiomyogenesis (BPM2,
Flk1, c-Kit, Isl1, Hrt1, Tbx5 and Nkx2.5) and in mature
cardiomyocytes (cTnI, MHC-b and ANF) remained strongly
downregulated through subculture steps 1 and 2 (Figure 3d).
Flow cytometry analysis was also performed to determine
whether the vasculogenic differentiation undertaken by the
EGF-induced ATMCs is associated with significant changes
in their cell surface marker phenotype (Figure 5b and
Supplementary Figure 4b). Consistent with their loss of
mesothelial characteristics through subculture steps, the
EGF-induced ATMCs displayed significant loss of CD54
expression from days 5 to 15 of culture (Po0.01). In turn,
CD44, a marker constitutively expressed on SMCs35 was
found to be significantly upregulated through subculture
(Po0.01).
EGF sequentially improves the proliferation and vascu-
logenic differentiation of ATMCs. Growth curves of
ATMCs cultured for 15 days in BMe or BMeþ 50EGF were
established (Supplementary Figure 2a) and fold increase in
cell numbers calculated at the end of each culture steps
(Supplementary Figure 2b). Comparative cell counts indi-
cated that ATMCs primary cultured in BMeþ 50EGF
proliferated more actively than in BMe cultures (5.64±0.35
versus 3.56±0.2-fold increase, respectively, Po0.001;
Supplementary Figure 2b). Such difference was, however,
Table 1 Summary of immunofluorescence analysis
Antigen Lineage distribution AT mesothelium ATMCs EMT VSM-like cells
Mesothelin Mesothelial and epithelial þ þ þ þ þ þ þ þ
b-Catenin Epithelial, mesothelial and endothelial þ þ þ þ þ þ þ þ /þ þ
ZO-1 Epithelial, mesothelial and endothelial þ þ þ þ þ *
E-cadherin Epithelial and mesothelial þ * þ þ þ þ *
CK18 Epithelial and mesothelial þ * þ  /þ þ  /þ
CK19 Epithelial and mesothelial ND þ /þ þ þ þ þ  /þ þ
WT1 Mesothelial þ þ þ þ  /þ þ
Vimentin Mesenchymal ND þ þ þ þ þ þ þ þ
Desmin SM, myofibroblasts and cardiac ND þ * þ /þ þ þ þ
a-SMA SMCs, myofibroblasts and myoepithelial   þ þ /þ þ þ þ þ þ
Calponin SMCs, myofibroblasts and myoepithelial ND  þ þ þ þ /þ þ þ
SM22a SMCs, myofibroblasts and myoepithelial ND   /þ þ þ /þ þ þ
SM-myosin SMCs, myofibroblasts and myoepithelial ND  þ þ þ þ þ þ
Caldesmon SMCs, myoepithelial cells and mesothelial ND þ * þ þ þ þ /þ þ þ
Smtn-B Vascular SM þ * þ * þ þ þ þ þ
PDGFRb SM and cardiac ND þ * þ þ þ þ /þ þ þ
Gata-4 Cardiac and SM progenitors ND  þ þ þ þ /þ þ þ
Isl1 Progenitors ND þ þ /þ þ þ
cTnT Cardiac ND  þ þ þ /þ þ
sACTN Cardiac ND  þ /þ þ þ þ /þ þ þ
Ki67 Proliferating cells ND  þ þ þ þ
Nestin Neuronal and SM progenitors ND  þ þ /þ þ þ þ /þ þ
CD45 Haematopoietic cells  /þ  /þ  
CD11b Monocytes and macrophages    
Sca1 Microvascular endothelial and progenitors þ */þ þ */þ þ  
CD44 Stromal þ * þ * þ þ /þ þ
CD106 Stromal mesenchymal and endothelial    
CD117 Haematopoietic and cardiac progenitors    
CD54 Endothelial and mesothelial þ þ þ þ þ þ þ þ þ /þ þ
CD29 Mesenchymal, epithelial and mesothelial þ /þ þ þ /þ þ þ þ þ þ þ þ
CD31 Endothelial    
CD90.2 Epithelial and mesenchymal þ */þ þ */þ þ /þ þ þ /þ þ þ
Abbreviations: a-SMA, alpha smooth muscle actin; CK18 and CK19, cytokeratins 18 and 19; cTnT, cardiac troponin T; HCAM, homing cell adhesion molecule;
ICAM-1, intercellular cell adhesion molecule 1; LCA, leukocyte common antigen; ND, not done; PECAM-1, platelet endothelial cell adhesion molecule 1; PDGFR-b,
platelet-derived growth factor receptor beta; sACTN, sarcomeric alpha actinin; Smtn-B, smoothelin B; VCAM-1, vascular cell adhesion molecule 1; WT1, Wilm´s
tumour protein 1; ZO-1, zona occludens 1
Immunofluorescence degrees: –, negative; þ *, very weak; þ , weak; þ þ , intermediate; þ þ þ , strong; EMT and VSM-like cells correspond to ATMCs cultured for
5 and 15 days in BMeþ 50EGF, respectively
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strongly reduced through their first subculture step
(2.9±0.36 versus 2.45±0.29-fold increase, respectively,
Po0.05) and finally became insignificant through their
second subculture step when cells drastically reduced
their proliferation as also indicated by Ki67 staining
(Supplementary Figure 2c).
ATMCs subcultured in BMeþ 50EGF were mainly fibro-
blastoid with prominent a-SMAþ stress fibres (Supplementary
Figure 6a). In turn, ATMCs subcultured in BMe rather
displayed epitheloid morphologies with only a minor subset
displaying transitional epitheloid–fibroblastoid appearance.
The partial SM differentiation of ATMCs subcultured in BMe
was also reflected on the basis of their diffuse a-SMA
cytoplasmic pattern. Correlating with this finding, collagen
gel lattices harbouring ATMCs subcultured in BMeþ 50EGF
contracted in significantly higher extent (Po0.01) than did
collagen gel lattices containing equal numbers of ATMCs
subcultured in BMe (Supplementary Figure 6b).
Figure 3 Quantitative RT-PCR analysis of the mRNA expression profile of ATMCs cultured into BMeþ 50EGF. The expression patterns of EMT (a), mesothelial (b), SM
(c) and cardiac (d and e) genes was compared between ATMCs cultured for 5, 10 and 15 days in BMeþ 50EGF and the freshly isolated ATMCs (black bars), which served as
the calibrator sample. Gene expression was normalized against expression levels of the housekeeping gene TBP. Results shown are the mean fold change±S.D. in mRNA
expression relative to the calibrator sample (set as 1) calculated from three independent enzymatic isolation of ATMCs and cultures into BMeþ 50EGF. Statistical significance
(*Po0.05 and **Po0.03) was determined by using Student’s t-test
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ATMC-derived VSM-like cells display vasoactive
agonist-induced contraction. The main function of
VSMCs is to contract and relax in response to vasoactive
agents. On this basis, we therefore aimed to evaluate the
contractile pattern of ATMC-derived VSM-like cells against a
wide range of vasoconstrictors (Table 2). To achieve this goal,
we used a sensitive contraction model previously developed in
our laboratory,18 which consisted in the generation of spheroids
aggregates of ATMC-derived VSM-like cells through suspen-
sion culture (Figure 6a). Replating of spheroids onto an
adherent surface allowed spreading cells to actively reorganize
in the form of multilayered spindle-shaped cells, which is a
cellular organization more closely to that of native contractile
SMCs. Immunofluorescence could confirm that the spreading
cells retained strong immunoexpression of SM22a, and aSMA
(Figure 6b) as well as of Smtn-B, caldesmon, CD44, CD29 and
CD90.2 (Supplementary Figure 7).
We then tested the ability of ATMC-derived VSM-like cells to
contract against vasoactive agonists by using time-lapse image
recording (Table 2). Consistent with their gain of VSMCs traits,
spreading ATMC-derived VSM-like cell spheroids invariantly
displayed intermediate to strong contractile responses to 50 nM
endothelin 1 (Supplementary Movie 1), 60 mM KCl (Supple-
mentary Movie 2) and 10mM vasopressin (Supplementary
Movie 3). Weak to intermediate contractile responses were also
recorded against 1 mM carbachol (Supplementary Movie 4),
10mM angiotensin-II (Supplementary Movie 5), 10mM oxytocin,
100mM norepinephrine and 100mM serotonin. For summary of
contractile responses see Table 2.
In most SMCs, the vasoconstrictor effect of endothelin-1
(ET1) is primarily mediated through its binding to the
endothelin subtype receptors ETA and in much lower extent
via ETB receptors.
36 To test whether ATMC-derived VSM-like
cells also acquired similar mechanisms, they were preincu-
bated with selective ETA and ETB receptors antagonists
before being challenged against 50 nM ET1 (Table 2). We
found that ATMC-derived VSM-like cells preincubated with
1 mM BQ-123 (ETA antagonist) displayed only weak contrac-
tile responses to 50 nM ET1 (Supplementary Movie 6), while
those preincubated with 1 mM BQ-788 (ETB antagonist)
exhibited moderate to strong contraction against 50 nM ET1
Figure 4 Western blotting analysis of phenotypic changes undertaken by
ATMCs upon sequential subculture into BMeþ 50EGF. Expression of markers
expressed in the mesothelial (a), SM (b) and cardiac (c) lineages as well as the
phosphorylation pattern of the EGF receptor, Akt, ERK1/2 and Smad2 (d) were
evaluated in freshly isolated ATMCs (0 h) and ATMCs after 3, 5, 10 and 15 days of
culture in BMeþ 50EGF. FVO, are proteins from mouse fetal (E17) visceral organs
(heart, lung and peritoneal organs). FH, are proteins from mouse fetal (E17) hearts
Figure 5 Summary of flow cytometry analysis of SMCs and lineage surface
markers expression into BMeþ 50EGF cultured ATMCs. (a) Intracellular flow
cytometry quantification of cells expressing SMCs markers (SM22a, caldesmon,
calponin, a-SMA, desmin and SM-myosin) among freshly isolated ATMCs (0 h),
ATMCs cultured for 5, 10 and 15 days in BMeþ 50EGF and the rat aortic VSMCs
line A7r5 VSMCs. (b) Quantification of percentages of cells expressing
haematopoietic (CD45 and CD11b), stem cells (CD117), mesenchymal and
stromal (CD44, Sca1, CD29, CD54, CD90.2) and endothelial (CD31, CD106)
surface markers in freshly isolated ATMCs (0 h) and ATMCs cultures for 5, 10 and
15 days in BMeþ 50EGF. (a and b) Results were deduced from n¼ 3 independent
cultures. Significant changes (þPo0.05; wPo0.03; zPo0.01) in marker
expression suffered by ATMCs through cultures steps (day 5 compared with 0 h;
day 10 compared with day 5 and day 15 compared with day 10) were evaluated by
using Student’s t-test. ATMCs cultured for 15 days into BMeþ 50EGF were also
compared against A7r5 VSMCs
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(Supplementary Movie 7). Only a combined preincubation
with both 1 mM BQ-123 and 1 mM BQ-788 could efficiently
abolish their ET1-induced contraction (Supplementary Movie 8).
Collectively, our results indicate that similarly observed in
most SMCs, ET1 mediates its vasoconstrictive action in
ATMC-derived VSM-like cells principally by acting through
ETA receptors and in much lower extent through ETB
receptors.
Discussion
The transdifferentiation protocol described here could effi-
ciently induced ATMCs to acquire molecular and functional
traits of differentiated VSMCs. This goal was achieved by
subjecting ATMCs to basal provasculogenic inductive culture
with serum17 and in combination with EMT-inducing factors
such as high glucose37,38 and EGF.17,39 The vasculogenic
differentiation of primary cultured ATMCs was further
improved towards VSMCs through repetitive disruption of
cell–cell interactions through sequential subculture steps and
at decreasing seeding density onto a collagen I-coated
surface. Their maturation towards differentiated VSMCs was
finally achieved through a step of cellular reaggregation under
suspension culture to generate a multilayered cellular
structure mimicking more closely the organization of
native SMCs.
We provide here evidences that EGF exerts both mitogenic
and EMT-inducing activities into serum-cultured ATMCs. EGF
mainly exerted a mitogenic effect on a subset of ATMCs in early
phases of culture, whereas its EMT-inducing activity was rather
patent during subculture. Accordingly, EGF was previously
shown to display potent mitogenic activity onto peritoneal
MCs.40 Although previous reports also identified the EMT-
inducing activity of distinct morphogenic growth factors such as
TGF-b1, bFGF and PDGF-BB onto serum-cultured adult MCs,
leading to their transdifferentiation into a-SMAþ , SM-myosinþ
and desminþ SM-like cells, none of them addressed their
functional status to determine whether they had acquired
molecular and functional characteristics of VSMCs.16,17,22–24
The finding that the early EGF-induced ATMCs expressed
markers consistent with progenitor cells (Gata-4, CD133 and
nestin), cardiomyocytes (sACTN, cTnT, SERCA2 and
MLC2a) and VSMCs (a-SMA, calponin, caldesmon, SM22a,
desmin, SM-MHC, smoothelin-B and PDGFR-b) led us to
hypothesize that distinct subsets of the EGF-induced ATMCs
initiated vasculogenic and cardiomyocytic differentiation
program. Our detailed qPCR analysis, however, evidenced
a clear down expression in the early EGF-induced cardiac
progenitors markers Isl1, c-Kit, Flk-1 and Nkx2.55,6,41 and of
BMP2, Tbx5 and Hrt1, which are involved during early cardiac
development, finding that may clearly exclude the emergence
in their culture of a cardiac progenitor population.
Table 2 Summary of vasoactive agonist-induced contractile responses
Vasoactive agonists ATMC-derived VSM-like cells Mouse vena cava SMCs Rat aortic SMCs
dH2Oþ50 nM ET1 þ þ (7) þ þ (1) þ þ þ (1)
1 mM BQ123þ50 nM ET1  /þ (2) ND ND
1 mM BQ788þ50 nM ET1 þ (2) ND ND
1 mM BQ123þ 1mM BQ788þ 50 nM ET1  (2) ND ND
60 mM KCl þ (5) þ þ (1) þ þ (1)
10mM Vasopressin þ2þ þ (7) þ þ (1) þ þ þ (1)
10mM Oxytocin  /þ2þ þ (4) þ (1) þ þ (1)
100mM Norepinephrine  /þ2þ þ (5) þ (1) þ (1)
100mM Serotonin  /þ2þ þ (4) þ (1) þ (1)
10mM Angiotensin II  /þ2þ þ (5) þ þ (1) þ þ þ (1)
1 mM Carbachol 2þ (5) þ (1) þ þ (1)
Abbreviations: ET-1, endothelin-1; ND, not done
BQ-123 (selective ETA receptors antagonist). BQ-788 (selective ETB receptors antagonist). ( ), is for a lack of contraction; ( /þ ), is for a weak contraction; (þ ), is
for a moderate contraction; (þ þ ), is for a strong contraction.2, indicates variation in contractile responses between independent cultures. (n), indicates number of
independent cultures tested
Figure 6 Generation of spreading ATMC-derived VSM-like cell spheroids for their use in contraction studies. (a) Schematic representation of steps performed to generate
ATMC-derived VSM-like cell spheroids. Right, phase contrast pictures of spheroid taken after 0 and 24 h of their transfer onto plastic adherent surface into BMeþ 50EGF.
Scale bar is 200mm. (b) Immunofluorescence characterization of SMCs markers (SM22a and aSMA) expression in spheroids fixed after 24 h of spreading onto plastic surface
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The coexpression of cardiac and VSMCs markers in part of
the EGF-induced ATMCs rather support the hypothesis that
only specific cardiac markers are expressed during the
vasculogenic differentiation of MCs. In strong support of this
emerging concept is a previous report that indicated how
human epicardial MCs subjected to serum culture coex-
pressed the SM markers a-SMA and SM-MHC together with
the cardiac markers Gata-4, cTnT and Cx43.16 In further
support of this finding, we also previously observed similar
coexpression pattern in murine UtMCs subjected to provas-
culogenic inductive conditions.18 Collectively, the confirma-
tion of similar findings in MCs isolated from three distinct
mesotheliums (heart, uterus and AT) strongly suggests that
the adult mesothelial lineage could retain intrinsic bipotency to
perform cardiomyogenic and leiomyogenic differentiation
depending on specific inductive stimuli. Further studies to
decipher putative cardiomyogenic inductive mechanisms for
adult MCs are under progress.
The coexpression of Isl-1 and SM-MHC in the early EGF-
induced ATMCs is very interesting because these markers
identify a population of VSMCs progenitors in the developing
human heart42 and in differentiating ESCs cultures.5,6
Interestingly, the early EGF-induced ATMCs were also found
to gain expression of the neural and progenitor cell marker
nestin, which is transiently expressed in VSMCs progenitors
of rat embryonic arteries.43 Collectively, the wide expression
of Isl1, SM-MHC, nestin and Smtn-B in the majority of the
early EGF-induced ATMCs is an unequivocal evidence of
their gain of traits of VSMCs progenitors, a finding which is in
strong support that adult ATMCs retain vasculogenic potential
similar to embryonic MCs.
The fact that our differentiation protocol could force ATMCs
to recapitulate an accurate leiomyogenic differentiation
program is unequivocally provided on the basis of the
acquisition of both molecular markers (PDGFR-b, a-SMA,
calponin, h-caldesmon, SM22a, desmin, SM-MHC and
Smtn-B) and functional hallmarks of differentiated VSMCs
(contractile responses to voltage (high Kþ ) and receptors
(ET1, vasopressin, oxytocin, noradrenaline, serotonin, angio-
tensin-II and carbachol)-induced contraction). We previously
described the acquisition of similar contractile mechanisms in
UtMC-derived VSM-like cells.18 Interestingly, both uterine
MC- and ATMC-derived VSM-like cells displayed the stron-
gest contractile responses recorded when stimulated with the
potent vasoconstrictor ET-1, which was shown to exert its
action principally through ETA receptors, which is the typical
mechanism of action of ET1 in most native SMCs types.36
Again, these findings obtained from two distinct mesotheliums
strongly support the concept that indistinctly of their anatomi-
cal origin, adult visceral MCs retain intrinsic potency to
transdifferentiate into VSMCs.
Overall, our results show that EGF signalling activation
potentiates the vasculogenic differentiation of serum-cultured
ATMCs, leading to their transdifferentiation towards functional
VSMC-like cells. Mechanistically, EGF signalling activation
was evidenced by an active phosphorylation of the EGF
receptor and the phosphorylation of its downstream signalling
pathways Erk1/2 and PI3K/Akt. Supporting our results, a
previous study already reported the active phosphorylation of
Erk1/2 and Akt in human ovarian MCs induced to undergo
EMT in response to their culture in a media containing
10 ng/ml EGF and 1mg/ml hydrocortisone.39 Furthermore,
phosphorylation of Erk1/2 and Akt was also reported in
EGF-induced proliferation of human bone marrow MSCs.44
Strikingly, the EGF-induced ATMCs also displayed activa-
tion of the Smad-dependent (Smad2/3) pathway, a pathway
that was previously reported to be activated in adult human
pleural and peritoneal MCs undergoing EMT in response to
TGF-b1 signalling.24,34,45 Interestingly, a previous study
indicated that high glucose was sufficient by itself to induce
an autocrine production of TGF-b1 in cultured human
peritoneal MCs46 and could therefore be a main effector of
the activation of the Smad-dependent pathway in our culture
model that is using a BMe.
Materials and Methods
Formulation of BMe and BMeþ50EGF media. BMe is a DMEM
GlutaMax high glucose (4.5 g/l) containing 25 mM HEPES medium (Gibco, Grand
Island, NY, USA; 32430), 10% heat inactivated fetal bovine serum (GE Healthcare
Life Sciences, HyClone Laboratories, Logan, UT, USA), 1% penicillin streptomycin
(Gibco), 100mM b-mercaptoethanol (Gibco, 31350-010). BMeþ 50EGF is BMe
supplemented with 50 ng/ml of mouse recombinant EGF (PeproTech, Rocky Hill,
NJ, USA; 315-09).
Isolation and culture of ATMCs. Visceral AT was isolated from sexually
mature non-pregnant OF1 adult female mice (6–24 weeks old). Guidelines for the
animal research protocols were established and approved by the Animal
Experimentation and Ethics Committee of CABIMER (CEEA-CABIMER) approved
the procedure (permit number 19-2010). ATMCs were obtained by incubating AT
depots in PBS containing 2% bovine serum albumin (BSA) and 0.25% trypsin
(Gibco) in a water bath at 37 1C for 20 min. In all, 3 105 ATMCs were plated per
well (3.5 104 cells/cm2) of a six-well tissue culture dishes (Nunc, Roskilde,
Denmark) into 2 ml BMeþ 50EGF and placed in an incubator (5% CO2, 37 1C).
Media were eliminated after 24 h to remove unbound cells and debris and then
exchanged every 48 h. ATMCs were then harvested after 5 days of culture with
0.05% trypsin and replated at 1.5 104 cells/cm2 in BMeþ 50EGF into Petri
dishes (140 mm, Nunclon D Surface, Nunc) coated with 1 mg/ml collagen type I
(C3867, Sigma-Aldrich, St. Louis, MO, USA) and subcultured for other 5 days.
After this, ATMCs were harvested and replated at 104 cells/cm2 into 140 mm Petri
dishes coated with collagen type I and containing BMeþ 50EGF and subcultured
again for other 5 days of duration.
Isolation and culture of primary rat aortic SMCs. Aortas were
isolated from Wistar adult rats with fine scissors, washed in PBS and incubated for
10 min in a 0.25% trypsin solution containing 2% BSA to detach perivascular and
endothelial cells. Aortas were then cut into small pieces and partially digested
during 10 min in a 2 mg/ml collagenase type-IA solution to obtain fragments of
medial SM layer. SM fragments were then transferred to a four-well dish (Nunc
Multidishes, Nunc, 176740) containing 400 ml of BMe. Media were partially
changed after 24 h. On day 2, once fragments had firmly adhered to the substrate,
the volume of media was completed to 1 ml. Migrating VSMCs were observable at
days 3–4 and cultured until they reached confluence and they were harvested with
0.05% trypsin. VSMCs were subcultured at 0.5 104/cm2 for other 7 days in BMe
and finally used to generate multilayered primary VSMCs cultures for their use in
contraction experiments.
Isolation and culture of primary mouse vena cava SMCs. Inferior
vena cava were isolated from CD1 adult female mice and cut into segments of
2 mm length that were incubated into PBS containing 0.25% trypsin and 2% BSA
to detach perivascular and endothelial cells. Segments were then transferred into
a 2 mg/ml collagenase IA solution and only partially digested during 10 min.
Resulting fragments were then collected and replated for explants culture onto
collagen I-coated 60 mm Petri dish into BMe media formulation. SMCs reached
confluence after 7 days of culture and were harvested for the generation of
spheroids and multilayered cultures for contraction as explained below for the
generation of ATMC-derived VSM-like cells multilayered cultures.
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Immunofluorescence. For immunofluorescence procedures, ATMCs were
cultured into hydrophilic m-Dish (Ibidi GmbH, Martinsried, Germany) following the
culture protocol described previously. For cell surface antigens, cells were fixed with
4% (wt/vol) paraformaldehyde. For intracellular antigens, cells were either
permeabilized with 0.5% Triton X-100 or with cold methanol (see Supplementary
Table S1). Blocking was done in PBSþ 3% BSA. Fluorescence images were
captured with an inverted fluorescence microscope Olympus IX71 equipped with
DPController and DPManager softwares (Olympus; www.olympus.co.uk). Nuclei
were counterstained with Hoechst 33342 (Sigma-Aldrich). F-actin was stained with
an Alexa Fluor 633 phalloidin antibody (Invitrogen, Carlsbad, CA, USA; A22284).
Primary and secondary antibodies used in this study are listed in Supplementary
Tables S1 and S2, respectively.
Whole-mount immunofluorescence. Freshly isolated AT depots were
fixed for 20 min in PBS containing 4% paraformaldehyde at 4 1C. AT depots were
then washed twice in PBS and cut into several pieces that were finally distributed
into a 24-well non-adherent plate. Samples were processed following the same
procedures as explained for immunofluorescence detection of surface and
intracellular markers. Nuclei were counterstained in PBS containing 1mg/ml
Hoechst 33342. Immunolabelled AT fragments were then finally mounted in
sandwich between two glass coverslips and immunofluorescent images were
taken with an inverted fluorescence microscope Olympus IX71.
Flow cytometry. For intracellular antigens, cells were permeabilized with
0.5% Triton X-100 and stained with primary and secondary antibodies listed in
Supplementary Tables S1 and S2, respectively. For surface antigens detection,
cells were fixed with 4% paraformaldehyde and stained in PBSþ 3% BSA
containing conjugated antibodies listed in Supplementary Table S3. Flow
cytometry analysis was performed with the use of a FACSCalibur Flow Cytometer
(BD FACSCalibur cytometry System, San Jose, CA, USA).
Generation of multilayered ATMC-derived VSM-like cell
spheroid cultures. ATMC-derived VSM-like cells (ATMCs isolated after 15
days of subculture in BMeþ 50EGF) were cultured (2 106 cells in 5 ml BMeþ 50
EGF per well) in an Ultra Low Attachment Plate (Costar, Thermo Fisher Scientific
Inc., Waltham, MA, USA; 3471) for 24 h to generate spheroids. A volume of 1.3 ml
BMEþ 50EGF media containing±50 spheroids was then transferred in each well
of a four-well plastic adherent culture dish (Nunc). Spheroids were pooled to the
centre of the well and cultured for a period of 24 h to initiate their spreading.
Time-lapse image recording. Vasoactive agonist-induced contraction of
spreading ATMC-derived VSM-like cell spheroids was determined by using time-
lapse image recording with the use of an inverted microscope Olympus IX71
having a prewarmed (±37 1C) working area as previously described.18 Phase
contrast images were taken at intervals of 20 s for a total duration of 20 min.
Premixed vasoactive agonists were added after 5 min of time-lapse recording.
Movies were produced from the sequence of phase contrast images recorded.
Collagen gel lattices contraction assay. We used a cell-collagen gel
lattice contraction assay to assess the contractile capacity of freshly isolated
ATMCs and of ATMCs cultured for 15 days in BMe or BMeþ 50EGF (ATMC-
derived VSM-like cells). Cell suspensions were adjusted to 106 cells/ml in cold 2X
a-MEM (Sigma-Aldrich, M0644) and adjusted to proportion 1:1 with a precooled
4.6 mg/ml rat tail collagen type I solution (BD Biosciences, San Jose, CA, USA;
354236). A volume of 750ml of each cell-collagen mixture was poured per well of
a 12-multiwells tissue culture plate (NunclonTM D Surface, Nunc, 150628) and
allowed to polymerize at 37 1C for 30 min. Lattices were mechanically released
from the well by gentle addition of 1 ml of BMe in each well. Digital photographs of
collagen gel lattices were taken after 24 h of their release from the well and used
to quantify lattices areas with MetaMorph Software (Molecular Devices
Corporation, Downingtown, PA, USA). Results are expressed as the mean±S.D.
of three independent experiments.
Vasoactive agonists and antagonists. Vasoactive agonists were: KCl
(60128), carbachol (C4382), endothelin 1 (E7764), angiotensin II (A9525), [Arg8]-
arginine vasopressin (V9879), oxytocin (O3251), norepinephrine (A9512) and
serotonin (H9523). Antagonists used were atropine (A0132), BQ-123 (B150) and
BQ-788 (B157). All were purchased from Sigma-Aldrich.
RNA extraction and qPCR analysis. Total RNA content was extracted
with Trizol reagent (Invitrogen), and total RNA (1 mg) was reverse-transcribed into
cDNA by using MMLV reverse transcriptase (Promega, Madison, WI, USA). qPCR
was performed using SYBR-Green and detected using an ABI Prism 7500 system
(Applied Biosystems, Foster City, CA, USA). Quantification of the mRNA level of
each gene was normalized to TBP mRNA (D101-D136, TATAA Biocenter AB,
Go¨teborg, Sweden). Primers sequences are listed in Supplementary Table S4.
Western blotting. Cells were lysed with RIPA buffer in the presence of
proteases and phosphatase inhibitor mixture. Forty microgram of total proteins
was separated by 8–10% Tris Glycine SDS-PAGE (Invitrogen) and transferred to a
polyvinylidene difluoride membrane (Hybond-P, Amersham, Buckinghamshire,
UK). Membranes were blocked in Tris-buffered saline with 2% BSA and 0.2%
Tween 20 and incubated overnight at 4 1C with primary antibodies listed in
Supplementary Table S1. Immunoreactive bands were detected with peroxidase-
conjugated secondary antibodies listed in Supplementary Table S2 and with ECL
Plus detection system (Amersham).
Statistics. Values are presented as mean ±S.D. Statistical significance was
calculated by using Student’s t-test, Po0.05 was considered significantly
different.
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